Category: PROGRESSIVE REVIEW
Liquid Biopsy: An Industrial Review
KEY POINTS The liquid biopsy market is forecasted to grow at a CAGR of 20.6 percent to reach over $3 ...
Biosimilars: The Evolution of a New Industry (Review)
KEY POINTS The global oncology mAb market is expected to reach around $45 billion by the end of this decade. ...
Migraine Treatment: The Current Status and New Effective Medicines in Trials (2018)
KEY POINTS Breakthrough discovery of the role of Calcitonin Gene-Related Peptide (CGRP) in the development of a migraine has created ...
NASH Disease: The Story of Industrial Ignorance and Attention
Highlights A comprehensive review of the past and current status of the Non-Alcoholic Steatohepatitis (NASH) drug discovery pipeline. Once thought to be ...